Drug Profile
HIV vaccine - Tria Bioscience
Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator TRIA Bioscience
- Developer Immune Design; TRIA Bioscience
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for HIV infections in USA (unspecified route) before September 2023
- 28 Aug 2020 No recent reports of development identified for preclinical development in HIV-infections in USA
- 15 Jul 2016 Preclinical trials in HIV infections in USA (unspecified route)